Status:
RECRUITING
Targeted Perfusion Based Haemodynamic Management in Critically Ill Patients Using Urethral Perfusion
Lead Sponsor:
King's College Hospital NHS Trust
Conditions:
Critically Ill
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To assess the safety and feasibility of the IKORUS device in critically ill patients and to gather exploratory data on haemodynamic coherence
Eligibility Criteria
Inclusion
- Within 24 h of ICU admission
- Predicted length of ICU stay at least 5 days
- Receiving \>0.1 mcg/kg/min of noradrenaline at time of study enrolment
Exclusion
- Palliative treatment intent
- Contra indication to urethral catheterisation or complication during previous urethral catheter insertion
- Contraindication to fluid or vasopressor challenges in the opinion of the attending clinician
Key Trial Info
Start Date :
April 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06158555
Start Date
April 1 2023
End Date
December 1 2024
Last Update
January 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King's College Hospital
London, United Kingdom, SE5 9RS